Giant Biogene Holding Co. Ltd. (HK:2367) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Giant Biogene Holding Co., Ltd. announced the successful adoption of all proposed resolutions at their Annual General Meeting (AGM) on June 13, 2024, including the re-election of executive directors and the re-appointment of Ernst & Young as auditor. Shareholders approved a final dividend of RMB0.44 and a special dividend of RMB0.45 per share for 2023. Additionally, the company received a mandate to repurchase and issue shares, and adopted amended corporate documents.
For further insights into HK:2367 stock, check out TipRanks’ Stock Analysis page.